Korro Bio (KRRO) Operating Expenses (2018 - 2026)

Korro Bio's Operating Expenses history runs 9 years deep, the most recent figure standing at $20.4 million for Q1 2026.

• Quarterly Operating Expenses fell 25.88% year-over-year to $20.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121.1 million (up 20.75% YoY) and the FY2025 annual result came in at $128.2 million, up 36.17% from the prior year.
• Operating Expenses was $20.4 million for Q1 2026 at Korro Bio, down from $51.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $51.7 million in Q4 2025 and bottomed at -$5.8 million in Q4 2022.
• A 5-year average of $22.7 million and a median of $21.5 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses tumbled 127.19% — and 2023, when it jumped 563.03%.
• Korro Bio's Operating Expenses stood at -$5.8 million in 2022, then soared by 563.03% to $26.9 million in 2023, then declined by 5.88% to $25.3 million in 2024, then soared by 104.21% to $51.7 million in 2025, then plunged by 60.46% to $20.4 million in 2026.
• Business Quant data shows KRRO's Operating Expenses at $20.4 million in Q1 2026, $51.7 million in Q4 2025, and $20.3 million in Q3 2025.